SIGRID Therapeutics today announced the U.S. launch of Carb Fence™, the company’s flagship medical food powered by patented SiPore® technology.
The launch represents a major commercialization milestone for SIGRID and the first market introduction of the clinically evaluated 9 g daily SiPore® protocol following more than 15 years of scientific development and clinical studies, including the SHINE study, one of the largest randomized controlled studies of its kind.